| 1 |
34529122 | Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value. | 2021 Dec |
2 |
| 2 |
24131339 | Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan. | 2013 Nov 13 |
1 |
| 3 |
23106890 | A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment. | 2012 Nov |
1 |
| 4 |
20830509 | ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. | 2011 Jan |
1 |
| 5 |
20075934 | One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors. | 2010 Apr |
1 |
| 6 |
20436124 | Randomised controlled trial: Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors. | 2010 Apr |
1 |
| 7 |
19591299 | [Combination therapy of ARB with diuretics in Japanese hypertensive patients]. | 2009 Jul |
1 |
| 8 |
19922995 | Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. | 2009 Nov 28 |
1 |
| 9 |
18199798 | ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. | 2008 Apr |
1 |
| 10 |
18360068 | A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors. | 2008 Jan |
1 |
| 11 |
18405793 | Cough induced by losartan with resolution after substitution with enalapril. | 2008 Mar |
2 |
| 12 |
18768350 | Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor. | 2008 Sep |
2 |
| 13 |
16960460 | Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism. | 2006 |
2 |
| 14 |
16128369 | Long-term combined therapy with losartan and an angiotensin-converting enzyme inhibitor improves functional capacity in patients with left ventricular dysfunction. | 2005 Aug |
1 |
| 15 |
14996614 | Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression. | 2004 Feb |
1 |
| 16 |
15080371 | Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist losartan in patients with hypertension. | 2004 Mar |
2 |
| 17 |
12507410 | New strategies for prevention of ischemic stroke: the LIFE study. | 2003 Jan |
1 |
| 18 |
12716812 | Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? | 2003 May |
1 |
| 19 |
11877567 | Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. | 2002 Mar |
1 |
| 20 |
12222553 | Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. | 2002 Sep |
1 |
| 21 |
12241832 | Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. | 2002 Sep 7 |
1 |
| 22 |
11211003 | Losartan and fetal toxic effects. | 2001 Feb 3 |
2 |
| 23 |
11588528 | T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans. | 2001 Oct |
2 |
| 24 |
11675956 | Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis. | 2001 Sep |
1 |
| 25 |
11801934 | Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. | 2001 Oct |
2 |
| 26 |
11811369 | Endothelial factors and microvascular hypertensive disease. | 2001 Nov |
1 |
| 27 |
12426159 | Relation of renin-angiotensin system gene polymorphisms and expressions with the efficacy of antihypertensive drugs. | 2001 |
2 |
| 28 |
10821361 | Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. | 2000 May 6 |
1 |
| 29 |
11054627 | Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial. | 2000 Nov |
2 |
| 30 |
11967824 | Acute effects of ACE inhibition on coronary endothelial dysfunction. | 2000 Dec |
2 |
| 31 |
10051289 | Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. | 1999 Mar 2 |
1 |
| 32 |
10336919 | Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study. | 1999 Jun |
1 |
| 33 |
10410812 | [Combined blockade of the renin-angiotensin system]. | 1999 Jun |
1 |
| 34 |
10483973 | EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction. | 1999 Sep |
1 |
| 35 |
9723827 | Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor. | 1998 Aug |
2 |
| 36 |
9793603 | Losartan as an alternative to ACE inhibitors in patients with renal dysfunction. | 1998 Oct |
3 |
| 37 |
9829449 | Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors. | 1998 Sep-Oct |
2 |
| 38 |
9010643 | A risk-benefit assessment of losartan potassium in the treatment of hypertension. | 1997 Jan |
1 |
| 39 |
9089428 | Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough. | 1997 Mar |
1 |
| 40 |
9160080 | Angioedema associated with angiotensin II receptor antagonist losartan. | 1997 May |
2 |
| 41 |
9205848 | Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease. | 1997 Jun |
1 |
| 42 |
9211022 | ACE inhibitors in heart failure: prospects and limitations. | 1997 May |
1 |
| 43 |
9316528 | Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. | 1997 Oct |
3 |
| 44 |
9335416 | Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure. | 1997 Oct |
2 |
| 45 |
9430872 | Effect of losartan on haemoglobin concentration in renal transplant recipients--a retrospective analysis. | 1997 Dec |
1 |
| 46 |
8792950 | Angiotensin II receptor antagonists: the prototype losartan. | 1996 Jun |
1 |
| 47 |
7664216 | Modulation of the renin-angiotensin-aldosterone system and cough. | 1995 Aug |
3 |
| 48 |
8583482 | ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. | 1995 Nov |
1 |
| 49 |
8583483 | The future role of losartan. | 1995 Nov |
1 |
| 50 |
18800451 | Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension. | 1995 Jul |
3 |